Clips on 'pancreas'

Follow

How GLP-1 Agonists Work to Lower Blood Sugar & Reduce Appetite

1:53 · AMA 64: New insights on GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape - Peter Attiaview episode

The Peter Attia Drive

1

Once We Can Cure Neurological Conditions, They'll Be Viewed No Differently Than Diabetes

3:25 · The Drive Interview with Peter Attiaview episode

Making Sense with Sam Harris

1

In Patients With Acute Pancreatitis, Probiotics Increase Death Risk

1:25 · Fun with Fermented Foods - Michael Greger, M.D.view episode

Nutrition Facts with Dr. Greger

0

Fasting Is Medical Bariatrics — It Reverses Type 2 Diabetes

7:33 · Jason Fung, M.D.: Fasting as a potent antidote to obesity, insulin resistance, type 2 diabetes, and the many symptoms of metabolic illness - Dr. Jason Fungview episode

The Peter Attia Drive

fat weight loss glucose fast

···

fasting nutrition insulin

11

Obesity & Insulin Resistance Are Protective Mechanisms Against Excess Insulin & Sugar

5:43 · Jason Fung, M.D.: Fasting as a potent antidote to obesity, insulin resistance, type 2 diabetes, and the many symptoms of metabolic illness - Dr. Jason Fungview episode

The Peter Attia Drive

sugar fat energy glucose

···

insulin obesity

2

Neglecting Traditional Treatment, Steve Jobs Died of a Pancreatic Endocrine Tumor

3:09 · 392: Life, Death, Darkness, and Light. "OUTLIVE" with Dr. Peter Attiaview episode

Jocko Podcast

0

Topic: pancreas

How GLP-1 Agonists Work to Lower Blood Sugar & Reduce Appetite

How GLP-1 Agonists Work to Lower Blood Sugar & Reduce Appetite

AMA 64: New insights on GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape - Peter Attia

0:00

1:53

0:00

1:53

How GLP-1 Agonists Work to Lower Blood Sugar & Reduce Appetite

AMA 64: New insights on GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape

AMA 64: New insights on GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape - Peter Attia

1 of 6

AMA 64: New insights on GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape - Peter Attia

1

+

1.0

-

+

1.0

-

0

ms